The first fish vaccine, ALPHA JECT® Panga ,1 received a Marketing Authorization from the Department of Animal Health, under Ministry of Agriculture and Rural Development (MARD) in Vietnam, on April 10.
"We are very pleased that the license is in place as this represents a breakthrough to both the Vietnamese seafood industry and to PHARMAQ", says Kjersti Gravningen, Director PHARMAQ Asia.
ALPHA JECT®Panga 1 is a vaccine for injection that provides protection against the bacteria Edwardsiella ictaluri causing disease in pangasius.
Vaccination is an important measure and step forward in controlling one of the major diseases in farmed pangasius in the Mekong Delta. " We feel confident that ALPHA JECT®Panga 1 is an efficient tool in reducing losses due to E. ictaluri and will contribute to improved fish health and increase the value of the fish," says Kjersti Gravningen.
"The vaccine is well documented through extensive field trials conducted in close co-operation with our customers over past two-year period.
"Our activities in Vietnam represent the first step of our strategy in the Asian aquaculture industry," says Morten Nordstad, CEO in PHARMAQ. "We are proud to hold the market authorisation for the first fish vaccine in Vietnam, and the company will continuously support the Vietnamese aquaculture industry towards more advanced fish health solutions."
- UK Mackerel stocks highest for 26 years
- Birds Eye may seek stock market listing -...
- Eustice buys time for Cornish sardine fishery
- Marine trout farming in south-west England
- International line up for seafood summit
- Scottish fishermen to highlight issues of...
- Fitch delivers stable outlook for Young's...
- Weeding out US fish killers
- Fishupdate Briefing
- Prince of Wales outlines oceans and fish s...